Cannabis remains one of the major risk factors for psychosis. New work by Nora Penzel from #kambeitzlab and the PRONIA Project indicates that particularly adolescence might be a vulnerable period due brain maturation: nature.com/articles/s4138…

My incredible Bloomwise co-founder Francesca Lewns has been shortlisted for the Start-Up Founder of the Year award at Midlands Women in Tech Awards 2022! Please cast your vote for her and spread the word. lnkd.in/eMBe8dk9 #womeninbusiness #womenintech #startup

In this cohort study, machine learning techniques revealed the substantial clinical and biological heterogeneity in early psychotic and affective illness. These findings may help identify targets for prevention. ja.ma/3d6YFH7

What a journey! Finally defended and celebrated my doctoral thesis on specific patterns of cannabis use as risk factors for psychosis. Thanks to my supervisors Nikolaos Koutsouleris Joseph Kambeitz friends and family #phddefence

🚨🚨New paper out🚨🚨 Published today in Neuropsychopharmacology we explored the effects of vaporised cannabis with these CBD:THC ratios – 0:1, 1:1, 2:1, 3:1 in healthy volunteers. ⬇️🧵 Institute of Psychiatry, Psychology & Neuroscience Medical Research Council #cannabis #CBD #THC nature.com/articles/s4138…

Work in computational image analysis? Want to start an exciting career Harvard Medical School Psychiatry Neuroimaging Lab? DM if interested in a post doctoral position working with medical and computational experts from different fields.

Excited to share our preprint using normative modeling to quantify sMRI deviations in CHR, evaluate their overlap w/ healthy variation, & links w/ symptoms & cognition! Huge thanks to Sophia Frangou GeRuiyang-蓋瑞洋 ENIGMA Consortium CHR Working Group dennis hernaus & @MJalbrzikowski!

2 postdoctoral positions available in my group: 1. MRI reconstruction using deep learning methods that are generalizable across domains. For this position prior experience in developing new deep learning techniques or MRI reconstruction is required.

⭐️Big News⭐️I got a #MSCA Postdoctoral Fellowship to study multimodal communication at CIMeC UniTrento Università di Trento. Thanks Marie Skłodowska-Curie Actions for the great opportunity! For future applicants: my thoughts, tips and experience below🧵1/17 Academic Chatter™ Times Higher Education The PostDocs Forum

Study Psichiatria Bari shows that cognitive &socio-cognitive #ML models transdiagnostically differentiate individuals with #BipolarDisorder & #Sz from HC, but key deficits differ between disorders. Models also identify early disorder but not at-risk stages bit.ly/3I2jKhy

Wonderful to catch up with Nora Penzel in-person in Toronto at Schizophrenia International Research Society 🎉🧠 Happy and proud to be a co-author on this incredible work! #SIRS2023

Are you a data scientist with an interest in mental health/a psychologist with advanced data science skills? Or come from a different background but fulfill the criteria? Then join my newly established lab Institute of Psychiatry, Psychology & Neuroscience with Nikolaos Koutsouleris! Pls share! #postdocposition #DataScience

Are you (or is someone you know) teaching AI / ML / Deep Learning this year? My forthcoming book (freely available at udlbook.com) will save you a lot of time. This thread will show you why.

Putting the spotlight on a 50-year-old debate, Davidson & William T. Carpenter discuss targeted vs. maintenance antipsychotic treatment of individuals with #schizophrenia in a new article Schizophrenia Bulletin. Find out which treatment is supported by the evidence in bit.ly/47tH1E2

Thrilled to share that I have received a Ph.D. prize from #dgppn2023 for my doctoral thesis about "specific patterns of cannabis use as risk factors for psychosis". Grateful for the guidance and support from my supervisors Joseph Kambeitz & Nikolaos Koutsouleris bit.ly/3GooKg0

A great opportunity to work with a great team and inspiring supervisors in a beautiful city! Check it out!

🚨 NEW PAPER 🚨 We compared many tuning procedures for developing prediction models Most important conclusion: be careful with using the popular 1-SE rule (e.g. in Ridge/Lasso) if calibration is important to you Open access in Statistics in Medicine 👉 doi.org/10.1002/sim.99…

Cognition is a core biomarker & key focus in the Accelerating Medicines Partnership® (AMP SCZ) initiative. Here the authors outline the rationale and harmonization of the cognitive battery #cognition #AMPSCZ Kelly Allott Walid Yassin @ScottWoods01 Patrick McGorry bit.ly/4iWAFmA

New paper revealing the intricate data operations behind the Accelerating Medicines Partnership® Schizophrenia (AMP® SCZ) project, managing data across two research networks comprising 43 international sites bit.ly/43NfHlS Schizophrenia International Research Society

Curious about predicting clinical outcomes? New paper in Schizophrenia Journal special issue shows how multidisciplinary experts shaped the AMP #Schizophrenia analysis strategy. Explore key decisions & data-driven insights! Schizophrenia International Research Society Nora Penzel Polo go.nature.com/4lYwQzv